Geoffrey O Littlejohn and Eric F Morand
Med J Aust 2002; 176 (1): . || doi: 10.5694/j.1326-5377.2002.tb04274.x
Published online: 7 January 2002

Recent major advances in rheumatology have been given further impetus by the declaration of 2000–2010 as the Bone and Joint Decade. This initiative, endorsed by the United Nations, aims to improve health-related quality of life for people with musculoskeletal disorders worldwide.

  • Centre for Inflammatory Diseases, Monash University, Monash Medical Centre, Clayton, VIC.

  • 1. Buchbinder R, Jolley D, Wyatt M. Population based intervention to change back pain beliefs and disability: three part evaluation. BMJ 2001; 322: 1516-1520.
  • 2. Sambrook P, Lane N. Corticosteroid osteoporosis. Best Prac Res Clin Rheumatol 2001; 15: 401-413.
  • 3. McAlindon T. Glucosamine for osteoarthritis: dawn of a new era? Lancet 2001; 357: 247-248.
  • 4. Brooks PM, Day ROD. COX-2 inhibitors. Med J Aust 2000; 173: 433-436. <eMJA full text>
  • 5. Furst DE, Breedveld FC, Burmester GR, et al. Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis. Ann Rheum Dis 2000; 59 Supp1: 1-2.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.